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Background: Scabies causes intense itching and skin lesions. A small number of studies have shown that scabies
impacts health-related quality of life (HRQoL), but no studies have been conducted in the Pacific region. We
assessed the impact of scabies on HRQoL in a high-prevalence setting using the Children’s Dermatology Life
Quality Index (CDLQI) and Dermatology Life Quality Index (DLQI). We also assessed the validity of these tools in
a Pacific Island population.
Methods: The study was conducted in the Solomon Islands. Participants with and without skin disease were
randomly selected. HRQoL indices were scored on a scale of 0–30.
Results: We surveyed 1051 adults (91 with scabies) and 604 children (103 with scabies). Scabies had a small
impact on HRQoL, with a median DLQI score of 2 (interquartile range [IQR] 0–6) and a CDLQI score of 2
(IQR 0–4). Scores increased linearly with severity. The greatest impact on QoL was due to itch, sleep disturbance
and impacts on education and employment.
Conclusions: Scabies has a small but measurable impact on HRQoL. The DLQI and CDLQI scores were discrimi-
nated between the skin-related QoL of patients with scabies and the control group, indicating that these tools
are appropriate to measure skin-related QoL in the Solomon Islands.
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Introduction
Scabies is caused by an infestation with themicroscopicmite Sar-
coptes scabiei var. hominis. This parasitic mite burrows into the
skin and reproduces, causing intense itch and skin lesions. These
lesions can become infected with bacteria, leading to impetigo,
invasive bacterial infections and serious immune-mediated com-
plications.1 Scabies is estimated to cause 455 million annual
incident cases globally, with the vast majority of cases occur-
ring in disadvantaged populations.2 According to the 2015 Global
Burden of Disease Study, scabies was responsible for 0.21% of
disability-adjusted life years (DALYs) of all 315 conditions included
in the study.3 The disability weight assigned to scabies was 0.027
on a scale of 0 (perfect health)–1 (death).3 This estimate of DALYs
and disability weight accounted for the primary effects of sca-
bies (itch and skin lesions) but did not consider the secondary
effects of bacterial infection, normortality related to crusted sca-
bies or bacterial complications, including invasive bacterial infec-
tions and immune-mediated diseases, or broader impacts of sca-
bies on quality of life.
Scabies contributes to morbidity as a result of both the clini-
cal pathology and emotional impact of the disease.4 Scabiesmay
impact a person in a number of ways: the intense itch can affect
sleep and concentration at school or work and the appearance of
lesions and the highly infectious nature of the disease can lead
to stigma.5 Secondary complications can result in hospitalisation,
cause long-term disability and may even be fatal.1 Four previous
studies have investigated health-related quality of life (HRQoL)
impacts in individuals with scabies. Studies were conducted in
Brazil (n=105, children and adults), China (n=96, adults only),
© The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. This is an Open Access
article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits














S Trust user on 18 August 2021
S. J. Lake et al.
India (n=102, children and adults) and Liberia (n=124, children
and adults).4, 6–8 All four studies used the Dermatology Life Qual-
ity Index (DLQI) or a modified version of the DLQI, three used the
Children’s Dermatology Life Quality Index (CDLQI) for paediatric
participants and one used the Family Dermatology Life Quality
Index (FDLQI). These studies found that scabies had a small to
moderate impact on HRQoL and that the impact was greater in
adults. The domains most impacted by scabies were embarrass-
ment and shame and work and study.
HRQoL is a multidimensional concept that captures physical,
emotional, psychosocial and social aspects of well-being and
can be measured using either generic or disease-specific instru-
ments.9 Generic instruments measure domains such as mobil-
ity and self-care and can be used across different disease areas.
Dermatology-specific instruments may be more sensitive to the
impact of skin disease onHRQoL.10,11 The DLQI and CDLQI are two
examples of validated surveys that have been used extensively
for skin conditions including psoriasis, atopic eczema and acne.12
While the DLQI is most commonly used, its limitations include
its focus on disability, cultural equivalence issues, item bias and
structure.13 The DLQI is not a preference-based tool, but map-
ping studies exist to convert DLQI scores to a preference-based
valuation that is relevant when assessing the cost-effectiveness
of interventions for scabies.14
Objectives
Our aimwas to assess the level and domains of impact of scabies
on HRQoL in children and adults. We also aimed to establish con-
struct validity for and suitability of the use of the DLQI and CDLQI
in a Pacific Island country.
Methods
Setting
This study was conducted in the Western Province of Solomon
Islands, a Melanesian country in the South Pacific comprised of
>900 islands with a population of approximately 700 000 peo-
ple.15 The most commonly spoken languages are English and
Pijin.16 Solomon Islands is classified as a least-developed country,
ranking 153 of 189 countries on the Human Development Index.
This study was conducted as part of the Regi-
mens of Ivermectin for Scabies Elimination (RISE) trial
(ACTRN12618001086257), a cluster-randomised non-inferiority
trial of one versus two doses of ivermectin for the control of
scabies.17 All participants in the study were offered treatment
for scabies as part of a mass drug administration campaign.
The RISE trial was conducted in 20 remote villages, each with a
population of 200–400 people. Most residents rely on subsistence
agriculture and fishing. Three of the study villages have a basic
health clinic staffed by nurses. Members of other villages travel
by foot or canoe for their medical care. The prevalence of scabies
in the study villages is 15%.18 Benzyl benzoate lotion is listed on
the Solomon Islands Essential Medicines List and is available free
of charge at health clinics for the treatment of scabies.
Study design
We conducted a cross-sectional study using the DLQI and CDLQI
instruments to assess the impact of scabies on HRQoL.11 All vil-
lage residents were eligible to participate in the RISE trial and
participants ≥4 y of age were eligible to take part in the HRQoL
assessment. We aimed to select approximately one-third of all
participants in the RISE trial to complete a DLQI or CDLQI ques-
tionnaire. The staff member administering the questionnaire ran-
domly selected participants and aimed to stratify the random
sample by gender and age group so that the sample was reflec-
tive of all RISE trial participants.
Nurses were trained to conduct clinical examinations of par-
ticipants to assess for scabies and impetigo.19 All participants in
the study were examined. The examination included history fea-
tures of scabies as well as examination of exposed areas (upper
and lower limbs in all participants and head and trunk in those
<2 y of age). Examinations took place in an open setting in the
village. Diagnosiswasmadeusing the 2020 International Alliance
for the Control of Scabies (IACS) Consensus Criteria for theDiagno-
sis of Scabies.20 Impetigo was defined as sores with papular, pus-
tular or ulcerative lesions surrounded by erythema or with crusts,
pus or bullae.18 Secondarily infected scabies lesions, abscesses
or cellulitis were also classified as impetigo for data analysis. The
severity of both scabies and impetigo was classified by the num-
ber of lesions (very mild, 1–2 lesions; mild, 3–10 lesions; moder-
ate, 11–50 lesions; severe, >50 lesions). Participants were con-
sidered free of skin disease if they had no rash (either scabies or
non-scabies), itch, infected sores, cellulitis, ulcers, abscesses or
boils.
QoL measurement tools
The DLQI (participants ≥15 y of age) and CDLQI (participants 4–
14 y of age) instruments were administered after a skin exam-
ination was completed. The questionnaires were administered
by the same staff member so that questioning was consistent.
The DLQI and CDLQI have not been validated in Solomon Islands
Pijin and literacy rates in villages were too low for participants
to self-administer the written questionnaire.16 The questionnaire
was therefore conducted verbally in English with Pijin translation
when required to provide clarification. Prior to commencing the
study, the questions were translated into Pijin by the study team
to ensure consistent clarification was provided. If the participant
was unable to communicate in English or Pijin the questionnaire
was not administered.
We conducted the DLQI and CDLQI among participants both
with and without scabies or other skin conditions. The partici-
pants without scabies were considered as controls in order to
establish the validity of the tools in this population, as there has
been no validation of the questionnaire in Pacific Island countries.
Participants free of skin conditions have been used as a control
population to establish the construct validity of the questionnaire
in other studies.12,21
Both the DLQI and CDLQIwere scored on a 4-point Likert scale,
with each of the 10 questions scored out of 3 points (0, ‘not at all’;
1, ‘a little’; 2, ‘a lot’; 3, ‘very much’), with the total score ranging
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Table 1. Demographic characteristics of participants
Characteristics Participants, n (%) Scabies, n (%) Other skin disease, n (%) No skin disease, n (%) All RISE trial participants, n (%)
CDLQI
Gender
Female 284 (47.0) 36 (35.0) 59 (43.4) 189 (51.8) 920 (48.7)
Male 320 (53.0) 67 (65.0) 77 (56.6) 176 (48.2) 968 (51.3)
Age (years)
4–9 261 (43.2) 41 (39.8) 67 (49.3) 153 (41.9) 1082 (57.3)
10–14 343 (56.8) 62 (60.2) 69 (50.7) 212 (58.1) 806 (42.7)
Total 604 103 136 365 1888
DLQI
Gender
Female 665 (63.3) 55 (60.4) 136 (59.6) 474 (64.8) 1527 (56.1)
Male 386 (36.7) 36 (39.6) 92 (40.4) 258 (35.2) 1197 (43.9)
Age (years)
15–19 152 (14.5) 16 (17.6) 34 (14.9) 102 (13.9) 383 (14.1)
20–39 481 (45.8) 47 (51.6) 94 (41.2) 340 (46.4) 1217 (44.6)
40–59 312 (29.7) 23 (25.3) 68 (29.8) 221 (30.2) 788 (28.9)
≥60 106 (10.1) 5 (5.5) 32 (14.0) 69 (9.4) 336 (12.3)
Total 1051 91 228 732 2724
scored as 0. During the analysis, scores were banded using an
established method to assess the level of impairment.22
Analysis
DLQI and CDLQI data were linked to skin examination data to
match survey responses to the clinical examination. The scores
were non-normally distributed, so we calculated both median
and mean (statistic most relevant for a cost-effectiveness anal-
ysis) scores for participants with scabies, impetigo, non-scabies
skin disease and without skin disease. We compared scores
according to the severity of scabies. We grouped children into
5-y age groups and adults into 20-y age groups. We analysed
the proportion of responses of participants with scabies who
had any impairment (a score of ≥1) in each of the domains.
Eight questions in the DLQI questionnaire include the option
of ‘not relevant’ as a response. A large number of ‘not rele-
vant’ responses can impact the DLQI score.23 We assessed the
proportion of ‘not relevant’ responses for each question and
recalculated an overall adjusted mean score (DLQI-R) using a
standard formula that removes the ‘not relevant’ items and
adjusts the total score for the relevant items.23 We used the
Wilcoxon rank sum (Mann–Whitney) test to assess the signif-
icance of the scores of participants with scabies and control
groups with a skin disease other than scabies and no skin
disease.
Study data were collected into a REDCap database using
an Android device by the staff member conducting the ques-
tionnaire. Data were managed using REDCap electronic data
capture tools hosted at Murdoch Children’s Research Institute
(Melbourne, Victoria, Australia). Data were analysed using Stata
version 14.2 (StataCorp, College Station, TX, USA).
Consent and ethical approval
Informed consent was required to participate in the study with
confirmation of consent either written or with thumbprint. Par-
ticipants were informed of the study aims and design through
provision of verbal and written information. Consent was pro-
vided by a parent or guardian for those <18 y of age. The study
was approved by the Solomon Islands Health Research and Ethics
Review Board (HRE005/18) and the Royal Children’s Hospital Mel-
bourne Human Research Ethics Committee (38099A).
Results
Participants
We surveyed 1051 adults and 604 children (Table 1), represent-
ing 35.9% of the 4612 participants in the RISE trial ≥4 y of age.
Among our sample, 91 adults and 103 children had scabies. The
sample was largely representative of those enrolled in the RISE
trial and the general population, although there was a lower pro-
portion of younger children (ages 4–9 y) and male adults com-
pared with the RISE trial (Table 1).
CDLQI/DLQI scores for participants with scabies
CDLQI scores for children and DLQI scores for adults were similar
(children: median 2 [IQR 0–4], mean 2.8 [95% confidence interval
{CI} 2.3 to 3.4]; adults: median 2 [IQR 0–6], mean 3.1 [95% CI 2.4
to 3.8]; Table 2). Both DLQI and CDLQI scores were significantly
different for participants with scabies comparedwith participants
without scabies (p<0.05). Among both children and adults, the
median andmean scores on the CDLQI andDLQI corresponded to
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Table 2. Banding of CDLQI and DLQI scores
CDLQI Scabies (n=103) Other skin disease (n=136)
Median score (IQR) 2 (0–4) 0 (0–0)
Mean score (95% CI) 2.8 (2.3 to 3.4) 0.8 (0.4 to 1.1)
Score, %
0 28.2 76.5
0–1, no effect 40.8 89
2–6, small effect 46.6 5.9
7–12, moderate effect 12.6 4.4
13–18, very large effect 0 0.7
19–30, extremely large effect 0 0
DLQI Scabies (n=91) Other skin disease (n=228)
Median score (IQR) 2 (0–6) 0 (0–1)
Mean score (95% CI) 3.1 (2.4 to 3.8) 0.8 (0.6 to 1.1)
Score, %
0 33 74.6
0–1, no effect 49.5 85.1
2–5, small effect 23.1 9.2
6–10, moderate effect 24.2 4.4
11–20, very large effect 3.3 1.3
21–30, extremely large effect 0 0
they were unlikely to seek treatment even if they had symptoms
of scabies.
CDLQI scores were higher in females than males (female chil-
dren: median 3 [IQR 0.5–5.5], mean 3.3 [95% CI 2.2 to 4.3];
male children: median 2 [IQR 0–4], mean 2.6 [95% CI 1.9 to
3.2]), whereas DLQI scores were higher in adult males than adult
females (adult females: median 1 [IQR 0–5], mean 2.8 [95% CI
1.9 to 3.7]; adult males: median 3.5 [IQR 0–6.5], mean 3.6 [95%
CI 2.4 to 4.7]) (Table 3), however, the IQRs and CIs were overlap-
ping across all groups. Scores among children were similar across
age groups. In adults, the highest score was in those 20–39 y of
age.
Scores for both children and adults increased with the severity
of scabies (children with severe scabies: mean 4.8 [95% CI 3.0 to
6.7]; adults with severe scabies: mean 7.8 [95% CI 4.2 to 11.4])
(Figure 1). In adults, the score for severe scabies corresponded to
a moderate impact on HRQoL. However, in children with severe
scabies the score still only corresponded to a small effect on
HRQoL. Participants with scabies affecting the lower limbs, head
or trunk had higher CDLQI and DLQI scores than those with sca-
bies affecting the upper limbs (Table 3).
The CDLQI items with the greatest impact on the total score
were related to skin itchiness (mean 1.0; 32% of those with sca-
bies reporting ‘quite a lot’ or ‘very much’), impact on schoolwork
(mean 0.6) and sleep (mean 0.5; Figure 2 and Supplementary
Table 1.1). ‘Symptoms and feelings’ was the domain with the
highest impact (70.9% scoring at least 1 point; Table 4) and this
was due to the symptoms rather than feelings. The mean score
for question 2 regarding feelings was the second lowest score
(mean 0.04). Among children, there was a greater impact on
girls in the personal relationships, leisure and school or holidays
domains.
Among adults, the items with the greatest impact were also
related to skin itchiness (mean 1.0; 33% of those with scabies
reporting ‘a lot’ or ‘verymuch’) and shopping, housework and gar-
dening (mean 0.4; Figure 3 and Supplementary Table 1.2). The
domain with the highest impact among adults was ‘symptoms
and feelings’ (67% scoring at least 1 point; Table 4). Similar to
children, the ‘feelings’ question in this domain had a low score
(mean 0.13). Among adults, the impact on leisure, work or school
and daily activities domain was greater in males.
Most questions of the DLQI had a low proportion (<20%) of
‘not relevant’ responses, with the exception of impact on work or
study, where 80.2% of participants with scabies responded ‘not
relevant’. We calculated an adjusted mean DLQI score (DLQI-R)
of 3.4 (95% CI 2.6 to 4.2) in participants with scabies, 0.2 (95%
CI 0.1 to 0.3) in participants with no skin disease and 0.8 (95% CI
0.6 to 1.1) in participants with a skin disease other than scabies.
Control group
Participants in the control group with no skin disease scored
a median CDLQI/DLQI score of 0 (range 0–13) and the control
group with a skin disease other than scabies scored a median
CDLQI/DLQI score of 0 (range 0–15). There was a significant dif-
ference in both DLQI and CDLQI scores in each control group
(p<0.05). Participants with a skin disease not diagnosed as sca-
bies scored a mean CDLQI score of 0.8 (95% CI 0.4 to 1.1) and a
mean DLQI score of 0.8 (95% CI 0.6 to 1.1) (Table 2). Participants
with no skin disease scored a mean CDLQI score of 0.2 (95% CI
0.1 to 0.3) and a mean DLQI score of 0.2 (95% CI 0.1 to 0.3). In
the ‘other skin disease’ group there were 16 adults and 28 chil-
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Table 3. CDLQI and DLQI scores for participants with scabies
Characteristics Participants, n CDLQI score Participants, n DLQI score
Gender
Female, median (IQR) 36 3 (0.5–5.5) 55 1 (0–5)
Mean (95% CI) 3.3 (2.2 to 4.3) 2.8 (1.9 to 3.7)
Male, median (IQR) 67 2 (0–4) 36 3.5 (0–6.5)
Mean (95% CI) 2.6 (1.9 to 3.2) 3.6 (2.4 to 4.7)
Age (years)
4–9, median (IQR) 41 2 (0–5)
Mean (95% CI) 2.8 (2.0 to 3.6)
10–14, median (IQR) 62 2 (0–4)
Mean (95% CI) 2.9 (2.1 to 3.6)
15–19, median (IQR) 16 1 (0–5)
Mean (95% CI) 2.8 (1.0 to 4.6)
20–39, median (IQR) 47 4 (0–7)
Mean (95% CI) 3.9 (2.8 to 4.9)
40–59, median (IQR) 23 1 (0–4)
Mean (95% CI) 2.0 (1.0 to 3.0)
≥60, median (IQR) 5 1 (0–3)
Mean (95% CI) 1.1 (0 to 5.2)
Location of scabies lesionsa
Upper limb, median (IQR) 103 2 (0–4) 87 2 (0–6)
Mean (95% CI) 2.8 (2.3 to 3.4) 3.1 (2.4 to 3.9)
Lower limb, median (IQR) 40 3 (1.5–5) 28 3.5 (0.5–6)
Mean (95% CI) 3.6 (2.6 to 4.5) 3.4 (2.2 to 4.7)
Head, median (IQR) 3 5 (3–5)
Mean (95% CI) 4.3 (1.5 to 7.2)
Trunk, median (IQR) 3 5 (3–7)
Mean (95% CI) 5 (0 to 10)
Skin condition present
Scabies no impetigo, median (IQR) 96 2 (0–4) 86 1.5 (0–6)
Mean (95% CI) 2.8 (2.2 to 3.4) 3.0 (2.3 to 3.7)
Scabies and impetigo, median (IQR) 7 3 (0–5) 5 4 (0–6)
Mean (95% CI) 3.3 (0.6 to 6.0) 4.2 (0 to 9.9)
Impetigo no scabies, median (IQR) 34 0 (0–0) 21 0 (0–0)
Mean (95% CI) 0.4 (0 to 0.9) 0.1 (0 to 0.2)
aParticipants may have lesions in more than one location.
diagnostic criteria for scabies due to a lack of supportive history
features (itch or contact history). For these participants themean
CDLQI score was 0.5 (95% CI 0.2 to 0.8) and themean DLQI score
was 1.4 (95% CI 0 to –2.7).
Discussion
We found that scabies affected HRQoL for both adults and chil-
dren, with an average impact of a ‘small effect’ on a person’s life.
The impact on HRQoL increased with the severity of scabies. The
results of a median score of 0 for the control group with no skin
disease demonstrate that the DLQI and CDLQI show specificity
in this population group. There is limited evidence for the use of
the DLQI and CDLQI in Pacific Island countries and these results
establish a construct validity in this setting.
Our study provides novel insights into the types of impacts
scabies has on HRQoL in a population with a high prevalence of
the disease and how this differs from other studies. The domain
most affected was ‘symptoms and feelings’ as a result of itch,
a common symptom of scabies. Among children in the study,
scabies had an impact on schoolwork in more than one-third of
participants. This effect could lead to a substantial impact on
education over time, particularly if the disease is left untreated
or is recurring, as is frequently the case in endemic settings.1
Among adults, activities of daily living were impacted by scabies
in approximately one-third of participants, also likely to lead to
an impact over time because many communities rely on sub-
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Figure 1. Mean score for the CDLQI and DLQI by scabies severity. Error bars indicate 95% CI: CDLQI, light blue; DLQI, dark blue).
Figure 2. Mean CDLQI score for each question for participants with scabies (n=103). Each question scores between 0 and 3. Error bars indicate
95% CI.
cause embarrassment, teasing, sexual difficulties or a change
the way people dress. This may be due to the high prevalence
of the disease in the community, where it is accepted as com-
mon, or it may reflect underreporting. Other studies that have
reported a greater impact of embarrassment or stigma had a
lower overall prevalence of scabies in the community or were
conducted among patients presenting to healthcare facilities and
thus would be more likely to have troublesome symptoms.4,6,7 It
was difficult in this field setting to achieve complete privacy for
participantswhen completing the questionnaire, whichmay have
contributed to underreporting. Treatment was rarely reported as
having an impact on HRQoL, possibly reflecting the low level of
treatment for scabies. Local nurses and participants reported to
the study team that the locally available treatment, benzyl ben-
zoate lotion, caused side effects and that treatment was fre-
quently futile because of reinfection from close contacts.
The level of impact of scabies on HRQoL in our study is com-
parable to previous studies. However, the areas of impact were
different, with the greatest impact due to the effects of symp-
toms. These differencesmay be explained by the high prevalence
and acceptance of scabies in our setting. The community-based
nature of the studymay have contributed to a lower overall score
compared with other studies carried out in clinics where patients
actively seek treatment.6,7
Neglected tropical diseases that affect the skin may have a
wide range of levels of impact. Scabies appears to be at the lower
end. For example, studies of filarial lymphoedema on HRQoL
showed DLQI mean scores ranging from 2.7 to 10.9.24,25 In
Ethiopian schoolchildren, both scabies and tungiasis were found
to have a similar impact on QoL, with a median CDLQI score
of 7 for both diseases.26 The minimal clinically important dif-
ference (MCID) of the DLQI, or the smallest difference in score
that a patient perceives as meaningful and justifies a change in
management, has not been established for scabies but is con-
sidered to be 4 for inflammatory conditions.27 If we accept this
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Table 4. Impairmenta of QoL in males and females with scabies by domain
Domain CDLQI questions Female (n=36), % Male (n=67), %
Symptoms and feelings 1,2 75 68.7
Personal relationships 3, 8 33.3 14.9
Leisure 4, 5, 6 33.3 23.9
School or holidays 7 41.7 32.8
Sleep 9 41.7 37.3
Treatment 10 2.8 3.0
Domain DLQI questions Female (n=55), % Male (n=36), %
Symptoms and feelings 1, 2 67.3 66.7
Daily activities 3, 4 34.5 44.4
Leisure 5, 6 23.6 41.7
Work and school 7 7.3 16.7
Personal relationships 8, 9 29.1 25.0
Treatment 10 0 5.6
aImpairment is equivalent to a score ≥1 in the domain.
Figure 3. Mean DLQI score for each question for participants with scabies (n=91). Each question scores between 0 and 3. Error bars indicate 95% CI.
meet this criteria, indicating that a change in management is
justified.
We used the standard DLQI and CDLQI questionnaires without
modifications. Cross-cultural inequivalence in HRQoL measures
should be taken into account when comparing results with other
settings.10 The sleep domain was a high-scoring domain in the
CDLQI in our study, reflecting the effect of scabies-related itch on
sleep quality. There is no sleep domain in the DLQI, which may
have led to an underestimation of the impact on HRQoL among
adults. Modified versions of the DLQI and CDLQI that are relevant
to scabies and to cultural setting have been used in other stud-
ies.4,6 Amodified version of the instrumentmay better reflect the
impact of scabies onHRQoL in this setting if it covered the gapswe
have identified. Further studies to measure the HRQoL of scabies
in Pacific Island countries could consider modifying the instru-
ment in the following ways: to capture the impact of symptoms
on sleep among adults, which was a high-scoring domain among
children; to better measure healthcare-seeking behaviour in rela-
tion to locally available treatment, whichmay not have been cap-
tured because of the way the treatment question was worded; to
more appropriately measure the impact on work as it relates to
a subsistence lifestyle, which may have been ambiguous in the
way work, housework and gardening were differentiated; and to
adapt the personal relationships domain in a culturally appropri-
ate way.
There are limitations to our study. First, the control group
used to establish a construct validity for this population group
was participants with no skin lesions detected on clinical exam-
ination. This examination was limited to exposed areas of the
body (hands and arms, legs and feet) and a focussed history,
and it is possible that some skin conditions were not identi-
fied. Second, the questionnaire was administered verbally. A
self-administered questionnaire may be answered more hon-
estly but was not possible due to low literacy.28 Third, our
results reflect the direct impact of scabies and impetigo infes-
tation and do not incorporate the impact of more severe sec-
ondary complications and therefore may underestimate the
impact. Finally, our study did not assess HRQoL in children
<4 y of age, a group with the highest prevalence of sca-
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studies may consider using the Infants Dermatitis IDQOL or
FDLQI.29,30
Our study demonstrates that scabies has a small, but mea-
surable, impact on HRQoL in Solomon Islands. We have estab-
lished a construct validity for the use of the DLQI and CDLQI in
this region that may extend to other Pacific Island populations.
We observed impacts on school, work and gardening that, in
this setting, impact an individual’s education, future prospects
and ability to support their family. In a setting where the pop-
ulation prevalence of scabies is 20%, this accounts for a large
impact on the community. There is scope to develop a modified
DLQI and CDLQI for scabies that is more culturally appropriate for
Pacific Island countries and may better measure the true impact
of this disease. The results of this study provide further evidence
of the need for elimination of scabies as a public health prob-
lem in Solomon Islands and other settings where the disease is
endemic.
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